Celleron Therapeutics announces encouraging clinical results with new cancer drug CXD101
Celleron Therapeutics, the UK-based company developing personalised medicine for cancer patients, has today announced that significant clinical activity was observed in the first human trial of its pioneering personalised ...
Dec 1, 2015